US medical device company Abbott has said it plans to launch a new range of 'biowearable' health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.
The FDA has published draft guidance on how digital health technologies (DHTs) like smart and wearable devices can be used to capture data remotely from patients in clinical trials – an app